ATC Group: A02BC05 Esomeprazole

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A02BC05 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A02 Drugs for acid related disorders
3 A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
4 A02BC Proton pump inhibitors
5 A02BC05 Esomeprazole

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 30 mg
PAREN - Parenteral 30 mg

Active ingredients in A02BC05

Active Ingredient Description
Esomeprazole

Esomeprazole is the S-isomer of omeprazole and reduces gastric acid secretion through a specific targeted mechanism of action. Esomeprazole is a weak base and is concentrated and converted to the active form in the highly acidic environment of the secretory canaliculi of the parietal cell, where it inhibits the enzyme H+ K+ -ATPase – the acid pump and inhibits both basal and stimulated acid secretion.

Related product monographs

Title Information Source Document Type  
EMAZOLE Gastro-resistant tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
NEXAZOLE Hard gastro-resistant capsule Health Products Regulatory Authority (IE) MPI, EU: SmPC
NEXIUM Gastro-resistant granules Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
NEXIUM Gastro-resistant tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
NEXIUM Powder for solution for injection / infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
TRUSTAN Gastric resistant tablet Health Products Regulatory Authority (ZA) MPI, Generic
VENTRA Gastro-resistant capsule, hard Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Austria (AT)

Canada (CA)

Croatia (HR)

Finland (FI)

France (FR)

Germany (DE)

Ireland (IE)

Israel (IL)

Japan (JP)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Romania (RO)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.